Table 2. Treatment outcome.

	First line n = 33 (%)	Second line n = 28 (%)
Best radiological objective response All Partial response Stable disease Progressive disease Objective response to XELOX Objective response to XELIRI	18 (54.5) 6 (18.2) 9 (27.3) 13/19 (68.4) 5/14 (35.7)	14 (50.0) 10 (35.7) 4 (14.3) 3/7 (42.9) 11/21 (52.4)
Median PFS in months (95% CI) All XELOX XELIRI XELOX versus XELIRI log rank p value	8 (3.3–12.7) 10 (5–15) 5 (3.2–6.8) 0.146	7 (5.1–8.9) 6 (4.2–7.8) 8 (6.5–9.5) 0.042
Median OS in months (95% CI) All XELOX XELIRI XELOX versus XELIRI log rank p value	25 (17.9–32.3) NR 21 (2.8–39) 0.203	20 (10.7–29.2) 24 (15.8–32.2) 20 (8.4–31.6) 0.864

NR: not reached